Ürümqi

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
A Study to Assess the Effectiveness and Safety of Ozanimod in Chinese Adults With Relapsing Multiple Sclerosis	Relapsing Multiple Sclerosis	Active, not recruiting	Phase 4	2025-04-16		NCT06396039

Clinical trials